Professor Carl Heneghan is a professor of Evidence-Based Medicine and the Director of the Centre for Evidence-Based Medicine (CEBM) and Programs in Evidence-Based Healthcare (EBHC) at the the Nuffield Department of Primary Care Health Sciences, University of Oxford. He is an NHS Urgent Care GP, and Co-Director of the Global Centre for Healthcare and Urbanisation, and a Fellow of Kellogg College, University of Oxford.
Professor Carl Heneghan is a clinical epidemiologist with expertise in Evidence-Based medicine, research methods, and evidence synthesis expertise. He has over 400 peer-reviewed publications (current H index 86); published 110 systematic reviews. His work includes investigating the evidence for approval of drugs and devices, assessing health claims and researching common presenting conditions in the community. He has investigated antivirals Tamiflu, acute respiratory infections and the transmission of SARs-CoV-2. He has expertise in medical device regulation, diagnosis and screening and avoidable le harms. Impact projects include the COVID-19 Evidence Service, anticoagulation care, Primodos & congenital malformations, the harms of transvaginal mesh and the transmission of SARs-CoV-2 (see cebm research)
He is a clinical adviser to two UK All Parliamentary Party Groups, an adviser to the WHO clinical trials registry platform. Twice he was voted one of the top 100 NHS clinical leaders by the HSJ. In 2018 he was awarded NIHR Senior Investigator status.
Research
His research interests include Evidence-Based medicine, primary care, general practice, diagnosis, evidence in influenza, patient self-monitoring and self-management, and non-communicable diseases such as cardiovascular disease, where he currently chairs WHO guidelines on self-care and cardiovascular disease risk.Professor Heneghan also investigates the evidence base for publication bias and drug and device regulation, and he is an international expert, advising governments, on the regulatory and evidence requirements for devices and drugs as well as Evidence-Based projects in the public interest. He is also a founder of the AllTrials campaign.Professor Carl Heneghan publishes Trust the Evidence Newsletter, discussing the latest research evidence to inform healthcare decisions.
The Oxford–Egypt EBHC Alliance focuses on advancing Evidence-Based healthcare education, research, and practice in Egypt, through a joint transformative initiative between leading academic, research and healthcare institutions in Egypt and the Oxford Centre for Evidence Based Medicine (CEBM) in the UK.
